Literature DB >> 1679866

Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children.

R W Sutter1, P A Patriarca, S Brogan, P G Malankar, M A Pallansch, O M Kew, A G Bass, S L Cochi, J P Alexander, D B Hall.   

Abstract

From January, 1988, to March, 1989, a widespread outbreak (118 cases) of poliomyelitis type 1 occurred in Oman. Incidence of paralytic disease was highest in children younger than 2 years (87/100,000) despite an immunisation programme that recently had raised coverage with 3 doses of oral poliovirus vaccine (OPV) among 12-month-old children from 67% to 87%. We did a case-control study (70 case-patients, 692 age-matched controls) to estimate the clinical efficacy of OPV, assessed the immunogenicity of OPV and extent of poliovirus spread by serology, retrospectively evaluated the cold chain and vaccine potency, and sought the origin of the outbreak strain by genomic sequencing. 3 doses of OPV reduced the risk of paralysis by 91%; vaccine failures could not be explained by failures in the cold chain nor on suboptimum vaccine potency. Cases and controls had virtually identical type 1 neutralising antibody profiles, suggesting that poliovirus type 1 circulation was widespread. Genomic sequencing indicated that the outbreak strain had been recently imported from South Asia and was distinguishable from isolates indigenous to the Middle East. Accumulation of enough children to sustain the outbreak seems to have been due to previous success of the immunisation programme in reducing spread of endemic strains, suboptimum efficacy of OPV, and delay in completing the primary immunisation series until 7 months of age. Additionally, the estimated attack rate of infection among children aged 9-23 months exceeded 25% in some regions, suggesting that a substantial proportion of fully vaccinated children had been involved in the chain of transmission.

Entities:  

Keywords:  Age Factors; Antibodies--analysis; Arab Countries; Asia; Biology; Case Control Studies; Delivery Of Health Care; Demographic Factors; Developing Countries; Diseases; Evaluation; Examinations And Diagnoses; Health; Health Services; Immunity; Immunization; Immunologic Factors; Incidence; Laboratory Examinations And Diagnoses; Measurement; Oman; Physiology; Population; Population Characteristics; Prevalence; Primary Health Care; Research Methodology; Retrospective Studies; Studies; Vaccination; Viral Diseases--prevention and control; Viral Diseases--transmission; Western Asia

Mesh:

Substances:

Year:  1991        PMID: 1679866     DOI: 10.1016/0140-6736(91)91442-w

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  21 in total

1.  Polio eradication--target 2000.

Authors:  S Gomber; K N Agarwal
Journal:  Indian J Pediatr       Date:  1996 Jul-Aug       Impact factor: 1.967

2.  Could an outbreak of poliomyelitis occur in the UK?

Authors:  S O Cameron; D Carrington; W Patterson
Journal:  BMJ       Date:  1992-01-04

3.  Polio eradication as 2000 approaches.

Authors:  A J Hall
Journal:  BMJ       Date:  1992-07-11

4.  Internal ribosomal entry site substitution eliminates neurovirulence in intergeneric poliovirus recombinants.

Authors:  M Gromeier; L Alexander; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

Review 5.  Poliomyelitis: present epidemiological situation and vaccination problems.

Authors:  C Mensi; F Pregliasco
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

6.  Successes and shortcomings of polio eradication: a transmission modeling analysis.

Authors:  Bryan T Mayer; Joseph N S Eisenberg; Christopher J Henry; M Gabriela M Gomes; Edward L Ionides; James S Koopman
Journal:  Am J Epidemiol       Date:  2013-04-16       Impact factor: 4.897

7.  Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus.

Authors:  A McGoldrick; A J Macadam; G Dunn; A Rowe; J Burlison; P D Minor; J Meredith; D J Evans; J W Almond
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

8.  Randomized, controlled trial of trivalent oral poliovirus vaccine (Sabin) starting at birth in Ghana.

Authors:  M Osei-Kwasi; E A Afari; K Mimura; I Obeng-Ansah; W K Ampofo; F K Nkrumah
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

9.  Evaluation of house-to-house versus fixed-site oral poliovirus vaccine delivery strategies in a mass immunization campaign in Egypt.

Authors:  R W Linkins; E Mansour; O Wassif; M H Hassan; P A Patriarca
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

10.  Clinical efficacy of trivalent oral poliomyelitis vaccine: a case-control study.

Authors:  N Deivanayagam; K Nedunchelian; S S Ahamed; S R Rathnam
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.